Bariatric Treatments

Metabolic Surgery for Type 2 Diabetes in Turkey

Metabolic surgery—also called diabetes surgery—is a specialised bariatric procedure performed primarily to achieve remission of type 2 diabetes mellitus rather than weight loss alone. Endorsed by the International Diabetes Federation and major endocrinology societies, metabolic surgery has been shown to be superior to intensive medical therapy in achieving long-term diabetes control. Turkey's leading hospitals offer this transformative treatment with multidisciplinary teams that include bariatric surgeons, endocrinologists, and diabetologists.

The Science Behind Metabolic Surgery

Metabolic surgery works through mechanisms that extend far beyond simple calorie restriction. By rerouting the digestive tract, the procedure alters the secretion of key gut hormones—including GLP-1, PYY, and ghrelin—that regulate insulin sensitivity, glucose metabolism, and appetite. These hormonal changes can produce dramatic improvements in blood sugar control within days of surgery, often before any significant weight loss occurs. This is why the procedure is classified as metabolic rather than purely bariatric.

Surgical Options

The most commonly performed metabolic procedures are the Roux-en-Y gastric bypass and the mini gastric bypass (OAGB), both of which incorporate the intestinal rerouting that drives hormonal change. The choice of procedure is determined by the patient's BMI, duration of diabetes, beta-cell function (measured by C-peptide levels), current medication requirements, and overall health profile. In selected cases, a duodenal switch or SADI-S procedure may be recommended for patients with more advanced metabolic disease.

Eligibility Criteria

Metabolic surgery is indicated for patients with type 2 diabetes and a BMI of 30 or above who have not achieved adequate glycaemic control (HbA1c above 7.5%) despite optimal medical therapy. Patients with a BMI of 27.5-30 may be considered in the presence of central obesity and metabolic syndrome. Ideal candidates have had diabetes for fewer than 10 years and retain adequate beta-cell function, as indicated by a C-peptide level above 1.0 ng/ml.

Outcomes and Evidence

Clinical studies demonstrate type 2 diabetes remission (HbA1c below 6.5% without medication) in 60-80% of patients following metabolic surgery, with the highest rates in patients with shorter disease duration and preserved beta-cell function. Even among patients who do not achieve complete remission, the majority experience significant reduction in medication requirements and improved cardiovascular risk profiles. The STAMPEDE trial showed superior outcomes for surgery compared to medical therapy at 5-year follow-up.

Recovery and Lifelong Management

Hospital stay is 3-4 nights with a 3-5 week recovery period. Post-operative care includes close monitoring of blood glucose levels, gradual tapering of diabetes medications under endocrinologist supervision, and lifelong nutritional supplementation. Regular metabolic health assessments are conducted at 3, 6, and 12 months, then annually thereafter.

Why Turkey for Metabolic Surgery?

Turkish metabolic surgery centres benefit from a high volume of international patients, enabling surgeons to accumulate exceptional experience. Integrated endocrinology and bariatric surgery departments at hospitals such as Memorial, Acıbadem, and Liv Hospital ensure seamless coordination of surgical and medical diabetes management.